Načítá se...
A novel use of cardiac resynchronization therapy‐defibrillator device in hypertrophic cardiomyopathy
Dual‐chamber implantable cardioverter‐defibrillator is generally used in patients with atrioventricular block and hypertrophic cardiomyopathy with preserved left ventricular ejection fraction. In the current case, a cardiac resynchronization therapy‐defibrillator device was implanted in a patient wi...
Uloženo v:
| Vydáno v: | Ann Noninvasive Electrocardiol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931796/ https://ncbi.nlm.nih.gov/pubmed/29846029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/anec.12559 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|